Navigation Links
Hybrid Fuels, Inc. Announces New Business Strategy
Date:12/5/2011

FORT LAUDERDALE, Fla., Dec. 5, 2011 /PRNewswire/ -- Hybrid Fuels, Inc., (Pink Sheets: HRID) announced today a reorientation of its main business activities and new strategic goals. 

The company will transform itself into a nutraceutical/pharmaceutical business venture that will focus on providing natural or nutraceutical solutions to medical conditions that would normally be treated or addressed with pharmaceutical drugs that are more damaging and can cause side effects that are sometimes even more harmful than the condition being treated.  The company's niche in the market place will be to provide nutraceutical alternatives and solutions to patients ranging from impotence, acne, cholesterol and many other common conditions. 

"Despite globalization, rocky economics and an uneasy healthcare system, the dietary supplement market continues to grow already boasting an estimated $25 billion in U.S. sales.  According to a survey conducted by Ipsos-Public Affairs for the Council for Responsible Nutrition, 65% of adult Americans (approx. 150 million) label themselves as supplement users.  The acquisition of EMG Marketing Solutions was the first step in implementing our new strategic goals focused on this evolving market.  EMB not only brings seasoned leadership in the nutraceutical industry but patented product formulations that are proven to help treat every day health conditions.  We look forward to announcing product lines in production over the next couple of weeks," stated Philip Schmidt, CEO of Hybrid Fuels, Inc.           

About Hybrid Fuels, Inc.

The company was incorporated in the state of Nevada in 1998 as Polo Equities.  It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies. 

Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Hybrid Fuels, Inc. undertakes no obligation to update such statements.

CONTACT:
Hybrid Fuels, Inc. - 954-903-2993

 


'/>"/>
SOURCE Hybrid Fuels, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hybrid Fuels, Inc. Acquires Marketing Company Focused on Multi-Billion Dollar Nutraceutical/Pharmaceutical Industry
2. MetroSouth Surgeon Pioneers Hybrid Treatment of Large Hiatal Hernias and Reflux
3. Cardicas Automated Anastomosis Systems Featured at Advances In Robotic And Hybrid Coronary Revascularization Meeting
4. Frost & Sullivan Award Highlights Hybridyne Technologies Outstanding Technology Innovation
5. Philips and ACC Address the Growing Demand for Minimally Invasive Cardiology Interventions by Showcasing Hybrid OR Solutions at ACC 2010
6. University of Michigan Study Shows SEQUENOMs MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
7. Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
8. WestPark Capital, Inc. Announces $2.6 Million IsoRay Offering
9. WestPark Capital Announces $2.6 Million IsoRay Offering
10. Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes
11. Physicians Capital Investments Announces Pedro Vergne-Marini, MD Named to Beckers ASC Review "350 People in the ASC Industry to Know"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in wound care advancements to physician colleagues, skilled nursing facility medical directors and ... the Treacherous Waters of Wound Care." , "At many of these conferences we ...
Breaking Medicine News(10 mins):